Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases. J of Skin [Internet]. 2022 Mar. 4 [cited 2025 Jun. 8];6(2):s21. Available from: https://skin.dermsquared.com/skin/article/view/1538